2021 ISFM Consensus Guidelines on the Collection and Administration of Blood and Blood Products in Cats

Samantha Taylor; Eva Spada; Mary Beth Callan; Rachel Korman; Ellie Leister; Paulo Steagall; Remo Lobetti; Mayank Seth; Séverine Tasker

doi:10.1177/1098612X211007071

2021 ISFM Consensus Guidelines on the Collection and Administration of Blood and Blood Products in Cats

Samantha Taylor^*, Eva Spada, Mary Beth Callan, Rachel Korman, Ellie Leister, Paulo Steagall, Remo Lobetti, Mayank Seth, Séverine Tasker

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

108 Downloads (Pure)

Abstract

PRACTICAL RELEVANCE: Blood and blood products are increasingly available for practitioners to use in the management of haematological conditions, and can be lifesaving and therapeutically useful for patients with anaemia and/or coagulopathies. It is important for feline healthcare that donors are selected appropriately, and transfusions of blood or blood products are given to recipients that will benefit from them. Complications can occur, but can be largely avoided with careful donor management and recipient selection, understanding of blood type compatibility, and transfusion monitoring.

CLINICAL CHALLENGES: Feline blood transfusion, while potentially a lifesaving procedure, can also be detrimental to donor and recipient without precautions. Cats have naturally occurring alloantibodies to red cell antigens and severe reactions can occur with type-mismatched transfusions. Blood transfusions can also transmit infectious agents to the recipient, so donor testing is essential. Finally, donors must be in good health, and sedated as appropriate, with blood collected in a safe and sterile fashion to optimise the benefit to recipients. Transfusion reactions are possible and can be mild to severe in nature. Autologous blood transfusions and xenotransfusions may be considered in certain situations.

EVIDENCE BASE: These Guidelines have been created by a panel of authors convened by the International Society of Feline Medicine (ISFM), based on available literature. They are aimed at general practitioners to provide a practical guide to blood typing, cross-matching, and blood collection and administration.

Original language	English
Pages (from-to)	410-432
Number of pages	23
Journal	Journal of Feline Medicine and Surgery
Volume	23
Issue number	5
Early online date	26 Apr 2021
DOIs	https://doi.org/10.1177/1098612X211007071
Publication status	Published - 1 May 2021

Bibliographical note

Funding Information:
Séverine Tasker has received financial support for infectious disease research from BSAVA PetSavers, Journal of Comparative Pathology Educational Trust, Langford Trust, Langford Vets Clinical Research Fund, Morris Animal Foundation, NERC/BBSRC/MRC, PetPlan Charitable Trust, South West Biosciences DTP, Wellcome Trust and Zoetis Animal Health. Paulo Steagall has provided consultancy services to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Procyon and Zoetis; has acted as a key opinion leader to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Vetoquinol and Zoetis; and has received speaker honoraria from Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco and Zoetis. The other members of the Panel have no conflicts of interest to declare.

Publisher Copyright:
© The Author(s) 2021.

Keywords

transfusion
plasma
xenotransfusion
transfusion reaction
blood type
cross-match

Access to Document

10.1177/1098612X211007071

Full-text PDF (author’s accepted manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via SAGE Publications at https://journals.sagepub.com/doi/10.1177/1098612X211007071 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 512 KB

Handle.net

Persistent link

Cite this

@article{a44b629bed3140a48b01217f0b0a5702,

title = "2021 ISFM Consensus Guidelines on the Collection and Administration of Blood and Blood Products in Cats",

abstract = "PRACTICAL RELEVANCE: Blood and blood products are increasingly available for practitioners to use in the management of haematological conditions, and can be lifesaving and therapeutically useful for patients with anaemia and/or coagulopathies. It is important for feline healthcare that donors are selected appropriately, and transfusions of blood or blood products are given to recipients that will benefit from them. Complications can occur, but can be largely avoided with careful donor management and recipient selection, understanding of blood type compatibility, and transfusion monitoring.CLINICAL CHALLENGES: Feline blood transfusion, while potentially a lifesaving procedure, can also be detrimental to donor and recipient without precautions. Cats have naturally occurring alloantibodies to red cell antigens and severe reactions can occur with type-mismatched transfusions. Blood transfusions can also transmit infectious agents to the recipient, so donor testing is essential. Finally, donors must be in good health, and sedated as appropriate, with blood collected in a safe and sterile fashion to optimise the benefit to recipients. Transfusion reactions are possible and can be mild to severe in nature. Autologous blood transfusions and xenotransfusions may be considered in certain situations.EVIDENCE BASE: These Guidelines have been created by a panel of authors convened by the International Society of Feline Medicine (ISFM), based on available literature. They are aimed at general practitioners to provide a practical guide to blood typing, cross-matching, and blood collection and administration.",

keywords = "transfusion, plasma, xenotransfusion, transfusion reaction, blood type, cross-match",

author = "Samantha Taylor and Eva Spada and Callan, {Mary Beth} and Rachel Korman and Ellie Leister and Paulo Steagall and Remo Lobetti and Mayank Seth and S{\'e}verine Tasker",

note = "Funding Information: S{\'e}verine Tasker has received financial support for infectious disease research from BSAVA PetSavers, Journal of Comparative Pathology Educational Trust, Langford Trust, Langford Vets Clinical Research Fund, Morris Animal Foundation, NERC/BBSRC/MRC, PetPlan Charitable Trust, South West Biosciences DTP, Wellcome Trust and Zoetis Animal Health. Paulo Steagall has provided consultancy services to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Procyon and Zoetis; has acted as a key opinion leader to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Vetoquinol and Zoetis; and has received speaker honoraria from Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco and Zoetis. The other members of the Panel have no conflicts of interest to declare. Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = may,

day = "1",

doi = "10.1177/1098612X211007071",

language = "English",

volume = "23",

pages = "410--432",

journal = "Journal of Feline Medicine and Surgery",

issn = "1098-612X",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - 2021 ISFM Consensus Guidelines on the Collection and Administration of Blood and Blood Products in Cats

AU - Taylor, Samantha

AU - Spada, Eva

AU - Callan, Mary Beth

AU - Korman, Rachel

AU - Leister, Ellie

AU - Steagall, Paulo

AU - Lobetti, Remo

AU - Seth, Mayank

AU - Tasker, Séverine

N1 - Funding Information: Séverine Tasker has received financial support for infectious disease research from BSAVA PetSavers, Journal of Comparative Pathology Educational Trust, Langford Trust, Langford Vets Clinical Research Fund, Morris Animal Foundation, NERC/BBSRC/MRC, PetPlan Charitable Trust, South West Biosciences DTP, Wellcome Trust and Zoetis Animal Health. Paulo Steagall has provided consultancy services to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Procyon and Zoetis; has acted as a key opinion leader to Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco, Vetoquinol and Zoetis; and has received speaker honoraria from Boehringer Ingelheim, Dechra Pharmaceuticals, Elanco and Zoetis. The other members of the Panel have no conflicts of interest to declare. Publisher Copyright: © The Author(s) 2021.

PY - 2021/5/1

Y1 - 2021/5/1

N2 - PRACTICAL RELEVANCE: Blood and blood products are increasingly available for practitioners to use in the management of haematological conditions, and can be lifesaving and therapeutically useful for patients with anaemia and/or coagulopathies. It is important for feline healthcare that donors are selected appropriately, and transfusions of blood or blood products are given to recipients that will benefit from them. Complications can occur, but can be largely avoided with careful donor management and recipient selection, understanding of blood type compatibility, and transfusion monitoring.CLINICAL CHALLENGES: Feline blood transfusion, while potentially a lifesaving procedure, can also be detrimental to donor and recipient without precautions. Cats have naturally occurring alloantibodies to red cell antigens and severe reactions can occur with type-mismatched transfusions. Blood transfusions can also transmit infectious agents to the recipient, so donor testing is essential. Finally, donors must be in good health, and sedated as appropriate, with blood collected in a safe and sterile fashion to optimise the benefit to recipients. Transfusion reactions are possible and can be mild to severe in nature. Autologous blood transfusions and xenotransfusions may be considered in certain situations.EVIDENCE BASE: These Guidelines have been created by a panel of authors convened by the International Society of Feline Medicine (ISFM), based on available literature. They are aimed at general practitioners to provide a practical guide to blood typing, cross-matching, and blood collection and administration.

AB - PRACTICAL RELEVANCE: Blood and blood products are increasingly available for practitioners to use in the management of haematological conditions, and can be lifesaving and therapeutically useful for patients with anaemia and/or coagulopathies. It is important for feline healthcare that donors are selected appropriately, and transfusions of blood or blood products are given to recipients that will benefit from them. Complications can occur, but can be largely avoided with careful donor management and recipient selection, understanding of blood type compatibility, and transfusion monitoring.CLINICAL CHALLENGES: Feline blood transfusion, while potentially a lifesaving procedure, can also be detrimental to donor and recipient without precautions. Cats have naturally occurring alloantibodies to red cell antigens and severe reactions can occur with type-mismatched transfusions. Blood transfusions can also transmit infectious agents to the recipient, so donor testing is essential. Finally, donors must be in good health, and sedated as appropriate, with blood collected in a safe and sterile fashion to optimise the benefit to recipients. Transfusion reactions are possible and can be mild to severe in nature. Autologous blood transfusions and xenotransfusions may be considered in certain situations.EVIDENCE BASE: These Guidelines have been created by a panel of authors convened by the International Society of Feline Medicine (ISFM), based on available literature. They are aimed at general practitioners to provide a practical guide to blood typing, cross-matching, and blood collection and administration.

KW - transfusion

KW - plasma

KW - xenotransfusion

KW - transfusion reaction

KW - blood type

KW - cross-match

U2 - 10.1177/1098612X211007071

DO - 10.1177/1098612X211007071

M3 - Article (Academic Journal)

C2 - 33896248

VL - 23

SP - 410

EP - 432

JO - Journal of Feline Medicine and Surgery

JF - Journal of Feline Medicine and Surgery

SN - 1098-612X

IS - 5

ER -

2021 ISFM Consensus Guidelines on the Collection and Administration of Blood and Blood Products in Cats

Abstract

Bibliographical note

Keywords

Access to Document

Handle.net

Fingerprint

Cite this